APPLICATION OF FE (2)-5-PYRIDYL BENZODIAZEPIN-2-ONES TO DETERMINATION OF SERUM IRON AND IRON-BINDING CAPACITY

被引：20

作者：

KLEIN, B

LUCAS, LB

SEARCY, RL

机构：

[1] Department of Diagnostic Research, Hoffmann-La Roche, Inc., Nutley

来源：

CLINICA CHIMICA ACTA | 1969年 / 26卷 / 03期

关键词：

D O I：

10.1016/0009-8981(69)90082-5

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

A precise procedure has been developed for the spectrophotometric determination of serum iron and iron-binding capacity using a new ligand-a 5-pyridyl benzodiazepin-2-one derivative. Procedural elements have been simplified for rapid analysis. By this technic, the iron content of normal human serum is : (males) 141 ± 25 (s.d.) μg/100 ml,iron-binding capacity, 230-484μ/100 ml; (females) 122 ± 30 (s.d.) μg/100 ml, iron-binding capcity, 264-385 μg/100 ml. These values are in good agreement with published values obtained by methods using other ligands. © 1969.

引用

页码：517 / &

共 17 条

[1] A SIMPLE METHOD FOR DETERMINATION OF IRON IN SERUM AND OTHER BIOLOGICAL MATERIALS [J].